Cargando…
Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation
Bortezomib is the first proteasomal inhibitor (PI) to be used therapeutically for treating relapse cases of multiple myeloma and mantle cell lymphoma. A proposed mechanism for its action is that it prevents the proteasomal degradation of proapoptotic proteins, leading to enhanced apoptosis. Although...
Autores principales: | ABD-AZIZ, NORAINI, STANBRIDGE, ERIC J., SHAFEE, NORAZIZAH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579903/ https://www.ncbi.nlm.nih.gov/pubmed/26622817 http://dx.doi.org/10.3892/ol.2015.3545 |
Ejemplares similares
-
Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53
por: Abd-Aziz, Noraini, et al.
Publicado: (2016) -
Recombinant Enterovirus 71 Viral Protein 1 Fused to a Truncated Newcastle Disease Virus NP (NPt) Carrier Protein
por: Mustafa, Suhaili, et al.
Publicado: (2020) -
HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia
por: Cimmino, Flora, et al.
Publicado: (2019) -
Calcitriol Suppresses HIF-1 and HIF-2 Transcriptional Activity by Reducing HIF-1/2α Protein Levels via a VDR-Independent Mechanism
por: Gkotinakou, Ioanna-Maria, et al.
Publicado: (2020) -
Immunization with recombinant enterovirus 71 viral capsid protein 1 fragment stimulated antibody responses in hamsters
por: Ch’ng, Wei-Choong, et al.
Publicado: (2012)